Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Orange, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Stefan Ciurea, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UC Irvine
- Stefan Ciurea, MD
Clinical Professor, Medicine, School of Medicine. Authored (or co-authored) 221 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Cartesian Therapeutics
- ID
- NCT04816526
- Phase
- Phase 2 Multiple Myeloma Research Study
- Study Type
- Interventional
- Participants
- Expecting 30 study participants
- Last Updated